CoChat

Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease

Open access
Shi, Ju, Wang, Qian, Johansson, Jenny U., Liang, Xibin, Woodling, Nathaniel S., Priyam, Prachi, Loui, Taylor M., Merchant, Milton, Breyer, Richard M., Montine, Thomas J., Andreasson, Katrin · 2012 · Annals of Neurology
Cited by 92

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Objective: There is significant evidence for a central role of inflammation in the development of Alzheimer disease (AD). Epidemiological studies indicate that chronic use of nonsteroidal anti‐inflammatory drugs (NSAIDs) reduces the risk of developing AD in healthy aging populations. As NSAIDs inhibit the enzymatic activity of the inflammatory cyclooxygenases COX‐1 and COX‐2, these findings suggest that downstream prostaglandin signaling pathways function in the preclinical development of AD. Here, we investigate the function of prostaglandin E 2 (PGE 2) signaling through its EP3 receptor in the neuroinflammatory response to Aβ peptide. Methods: The function of PGE 2 signaling through its EP3 receptor was examined in vivo in a model of subacute neuroinflammation induced by administration of Aβ 42 peptides. Our findings were then confirmed in young adult APPSwe‐PS1ΔE9 transgenic mice. Results: Deletion of the PGE 2 EP3 receptor in a model of Aβ 42 peptide‐induced neuroinflammation reduced proinflammatory gene expression, cytokine production, and oxidative stress. In the APPSwe‐PS1ΔE9 model of familial AD, deletion of the EP3 receptor blocked induction of proinflammatory gene and protein expression and lipid peroxidation. In addition, levels of Aβ peptides were significantly decreased, as were β‐secretase and β C‐terminal fragment levels, suggesting that generation of Aβ peptides may be increased as a result of proinflammatory EP3 signaling. Finally, deletion of EP3 receptor significantly reversed the decline in presynaptic proteins seen in APPSwe‐PS1ΔE9 mice. Interpretation: Our findings identify the PGE 2 EP3 receptor as a novel proinflammatory, proamyloidogenic, and synaptotoxic signaling pathway, and suggest a role for COX‐PGE 2‐EP3 signaling in the development of AD. ANN NEUROL 2012;72:788–798

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.23677

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 92

Metadata

Authors
Shi, J., Wang, Q., Johansson, J. U., Liang, X., Woodling, N. S., Priyam, P., Loui, T. M., Merchant, M., Breyer, R. M., Montine, T. J., & Andreasson, K.
Venue
Annals of Neurology
Publisher
Wiley
Published
2012-08-22
Volume
72
Issue
5
Pages
788-798
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W1946356711
Cited by
92
References
17
FWCI
6.79
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease. https://app.cochat.ai/papers/10.1002/ana.23677
The paper
Shi, J., Wang, Q., Johansson, J. U., Liang, X., Woodling, N. S., Priyam, P., Loui, T. M., Merchant, M., Breyer, R. M., Montine, T. J., & Andreasson, K. (2012). Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease. Annals of Neurology. https://doi.org/10.1002/ana.23677

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.